↓ Skip to main content

A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer

Overview of attention for article published in BMC Cancer, March 2017
Altmetric Badge

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
34 Mendeley